Palatability Testing of a New Paediatric Formulation of Valacyclovir — VALID-0

Herpes Simplex Virus Infection Clinical Trial

Official title:
Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children

Status Completed

Clinical Trial Summary

Palatability testing of a new paediatric formulation of valacyclovir in children 4-12 years of age and at least one of their parents. Children will be included, who received (val)acyclovir prophylaxis in the past, or will probably need it in the future i.e. children with primary immune deficiency or cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01682109
Study type	Interventional
Source	Radboud University
Contact
Status	Completed
Phase	Phase 4
Start date	September 2012
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05198570` - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Recruiting	`NCT05532540` - Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
Recruiting	`NCT05604911` - Herpes Virus Infections in Kidney Transplant Patients
Not yet recruiting	`NCT05664152` - An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years	N/A
Completed	`NCT01689285` - Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir	Phase 1
Terminated	`NCT04081480` - Pharmacokinetics of Valacyclovir Oral Solution in Children	N/A
Recruiting	`NCT04403139` - VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination	Phase 4